← BICYCLE THERAPEUTICS PLC
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | ($21.8m) | ($30.6m) | ($51.0m) | ($66.8m) | ($112.7m) | ($180.7m) | ($169.0m) | ($219.0m) | ($190.4m) | |
| Net loss | ($16.3m) | ($21.8m) | ($30.6m) | ($51.0m) | ($66.8m) | ($112.7m) | ($180.7m) | ($169.0m) | ($219.0m) | — | |
| Depreciation, Depletion and Amortization | $332k | $712k | $960k | $1.3m | $1.4m | $3.7m | $6.5m | $7.2m | $6.4m | $5.3m | |
| Depreciation | $332k | $700k | $1.0m | $1.3m | $1.4m | $3.7m | $6.5m | $7.2m | $6.4m | $5.3m | |
| Depreciation Amortization Depletion | — | — | — | — | — | $3.7m | $6.5m | $7.2m | $6.4m | $5.3m | |
| Deferred Income Tax Expense (Benefit) | — | ($378k) | ($364k) | ($673k) | ($1.7m) | ($5.0m) | $3.3m | ($5.2m) | ($850k) | $882k | |
| Deferred Tax | — | — | — | — | — | ($5.0m) | $3.3m | ($5.2m) | ($850k) | $882k | |
| Share-based Payment Arrangement, Noncash Expense | — | $1.0m | $3.1m | $6.5m | $12.1m | $26.8m | $32.5m | $38.1m | $39.5m | $33.8m | |
| Share-based Payment Arrangement, Expense | — | $1.0m | $3.1m | $6.5m | $12.1m | $26.8m | $32.5m | $38.1m | $39.5m | $33.8m | |
| Share-based compensation expense | $515k | $1.0m | $3.1m | $6.5m | $12.1m | $26.8m | $32.5m | $38.1m | $39.5m | $33.8m | |
| Other Nonoperating Income (Expense) | — | ($665k) | ($5.4m) | — | — | — | — | — | — | — | |
| Nonoperating Income (Expense) | — | ($496k) | ($4.6m) | $226k | ($2.9m) | $2.4m | $10.7m | $36.1m | $28.3m | — | |
| Changes in operating assets and liabilities: | |||||||||||
| Change In Working Capital | — | — | — | — | — | $672k | $76.7m | ($33.4m) | ($75.8m) | ($55.6m) | |
| Increase (Decrease) in Accounts Receivable | — | $400k | ($4.9m) | $2.1m | ($4.5m) | $1.6m | ($2.5m) | — | — | $11.1m | |
| Accounts receivable | — | ($400k) | $4.9m | ($2.1m) | $4.5m | ($1.6m) | $2.5m | — | — | $11.1m | |
| Change In Receivables | — | — | — | — | — | ($11.3m) | ($1.2m) | ($11.9m) | $2.9m | $11.1m | |
| Changes In Account Receivables | — | — | — | — | — | ($1.6m) | $2.5m | $0 | $0 | $11.1m | |
| Increase (Decrease) in Accounts Payable | $67k | ($169k) | $220k | ($663k) | $1.2m | $2.6m | $8.0m | $3.1m | ($6.9m) | ($11.8m) | |
| Changes in purchases of property and equipment in accounts payable and accrued expenses | — | — | — | — | $324k | $1.6m | ($1.7m) | ($4k) | — | — | |
| Change In Payables And Accrued Expense | — | — | — | — | — | $14.9m | $10.4m | $12.8m | ($2.8m) | ($11.8m) | |
| Accrued expenses and other current liabilities | $1.3m | $2.6m | ($852k) | $4.8m | $1.2m | $12.4m | $2.4m | $9.7m | $4.1m | — | |
| Deferred revenue | $14.1m | ($3.9m) | ($9.3m) | $24.6m | $37.1m | ($2.1m) | $69.0m | ($32.0m) | ($69.2m) | — | |
| Change In Accrued Expense | — | — | — | — | — | $12.4m | $2.4m | $9.7m | $4.1m | $171k | |
| Prepaid expenses and other assets | ($330k) | ($1.3m) | ($2.7m) | ($49k) | ($3.0m) | ($2.0m) | ($2.1m) | ($2.0m) | ($5.8m) | — | |
| Restricted cash included in other assets | — | — | — | — | — | $0 | $547k | $547k | $58k | — | |
| Change In Other Current Assets | — | — | — | — | — | $2.7m | $4.2m | $4.4m | $4.6m | $4.1m | |
| Change In Other Current Liabilities | — | — | — | — | — | ($1.4m) | ($3.6m) | ($4.7m) | ($5.5m) | ($4.8m) | |
| Net Cash Provided by (Used in) Operating Activities | ($1.4m) |
($26.1m)
-1742.97%
|
($28.6m)
-9.72%
|
($17.8m)
+37.83%
|
($14.8m)
+16.84%
|
($86.1m)
-482.07%
|
($60.6m)
+29.59%
|
($164.7m)
-171.70%
|
($249.7m)
-51.57%
|
($206.1m)
+17.47%
|
|
| Cash flows from investing activities: | |||||||||||
| Property and equipment obtained under finance leases | — | — | — | — | — | — | — | $1.1m | — | — | |
| Payments to Acquire Property, Plant, and Equipment | ($1.1m) | $1.2m | $1.6m | $1.2m | $2.0m | $19.0m | $2.9m | $1.2m | $2.4m | ($2.2m) | |
| Net Cash Provided by (Used in) Investing Activities | ($1.1m) | ($1.2m) | ($1.6m) | ($1.2m) | ($2.0m) | ($19.0m) | ($2.9m) | ($1.2m) | ($2.4m) | ($2.2m) | |
| Cash flows from financing activities: | |||||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | — | — | ($954k) | — | — | |
| Issuance Of Debt | — | — | — | — | $15.0m | $0 | $0 | — | — | — | |
| Long Term Debt Issuance | — | — | — | — | $15.0m | $0 | $0 | ($31.9m) | ($168k) | — | |
| Net Issuance Payments Of Debt | — | — | — | — | — | $0 | $0 | ($31.9m) | ($168k) | ($196k) | |
| Repayments of Long-term Debt | — | — | — | — | — | — | — | $31.9m | — | ($196k) | |
| Long Term Debt Payments | — | — | — | — | — | $0 | $0 | ($31.9m) | ($168k) | ($196k) | |
| Repayment Of Debt | — | — | — | — | — | $0 | $0 | ($31.9m) | ($168k) | ($196k) | |
| Issuance Of Capital Stock | — | — | — | — | — | $5.7m | $249.3m | $544.1m | $0 | ($979k) | |
| Proceeds from Issuance of Common Stock | — | — | — | — | $7.6m | $5.7m | $249.3m | $544.1m | — | ($979k) | |
| Common Stock Issuance | — | — | — | — | — | $5.7m | $249.3m | $544.1m | $0 | ($979k) | |
| Net cash (used in) provided by financing activities | $57.9m |
$25.4m
-56.06%
|
$58.4m
+129.81%
|
$62.8m
+7.53%
|
$320.7m
+410.36%
|
$6.7m
-97.91%
|
$250.0m
+3636.21%
|
$519.8m
+107.88%
|
($131k)
-100.03%
|
— | |
| Net Cash Provided by (Used in) Financing Activities | — | $25.4m |
$58.4m
+129.81%
|
$62.8m
+7.53%
|
$320.7m
+410.36%
|
$6.7m
-97.91%
|
$250.0m
+3636.21%
|
$519.8m
+107.88%
|
($131k)
-100.03%
|
($149k)
-13.74%
|
|
| Net increase (decrease) in cash, cash equivalents and restricted cash | $58.3m | ($4.3m) | $28.7m | $43.9m | $302.7m | ($99.5m) | $187.8m | $353.1m | ($251.4m) | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($4.3m) | $28.7m | $43.9m | $302.7m | ($99.5m) | $187.8m | $353.1m | ($251.4m) | $513.6m | |
| Beginning Cash Position | — | — | — | — | — | $438.7m | $339.2m | $527.0m | $880.1m | $722.0m | |
| Cash, cash equivalents and restricted cash at beginning of period | $67.7m | $63.4m | $92.1m | $136.0m | $438.7m | $339.2m | $527.0m | $880.1m | $628.7m | — | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | ($2.4m) | $465k | $19k | ($1.2m) | — | — | — | — | ($3.5m) | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | — | — | — | $19k | ($1.2m) | ($1.1m) | $1.3m | ($694k) | $804k | ($3.5m) | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $63.4m | $92.1m | $136.0m | $438.7m | $339.2m | $527.0m | $880.1m | $628.7m | $513.6m | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Income Tax Expense (Benefit) | — | ($396k) | ($254k) | ($724k) | ($1.7m) | ($1.5m) | $1.5m | ($4.8m) | $152k | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | $1.7m | $206k | — | |
| Operating lease rightofuse assets | — | — | $712k | $771k | $404k | $2.7m | $4.2m | $4.4m | $4.6m | — | |
| Operating lease liabilities | — | — | ($709k) | ($621k) | ($582k) | ($2.1m) | ($4.1m) | ($4.9m) | ($5.5m) | — | |
| Additional Financial Items | |||||||||||
| Proceeds from Stock Options Exercised | — | $1k | $143k | $271k | $7.2m | $989k | $682k | $7.5m | $37k | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | — | — | ($600k) | ($600k) | ($700k) | $700k | — | |
| Foreign Currency Transaction Gain (Loss), Realized | — | $300k | $900k | $600k | $400k | — | — | — | — | — | |
| General and Administrative Expense | — | $8.1m | $14.6m | $29.2m | $32.4m | $49.5m | $60.4m | $72.2m | $79.4m | — | |
| Operating Expenses | — | $28.9m | $40.1m | $62.4m | $77.3m | $131.1m | $216.9m | $245.1m | $319.7m | — | |
| Non-cash interest | — | — | — | $78k | $468k | $442k | $383k | $211k | — | — | |
| Other non-cash charges | — | — | — | — | — | — | $661k | $1.0m | — | — | |
| Research and development incentives receivable | ($1.4m) | ($3.6m) | ($383k) | ($1.8m) | ($1.9m) | ($9.7m) | ($3.7m) | ($11.9m) | $2.9m | — | |
| Other long-term liabilities | $383k | $543k | $1.1m | $517k | $710k | $668k | $509k | $189k | — | — | |
| Proceeds from the issuance of ADSs and non-voting ordinary shares, net of issuance costs | — | — | — | $48.1m | $7.6m | $5.7m | $249.3m | $544.1m | — | — | |
| Proceeds from the exercise of share options and settlement of restricted share units | $1k | $1k | $143k | $271k | $7.2m | $989k | $682k | $7.5m | $37k | — | |
| Principal payments on finance lease obligations | — | — | — | — | — | — | — | ($42k) | ($168k) | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | $6.7m | $250.0m | $519.8m | ($131k) | ($149k) | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | ($19.0m) | ($2.9m) | ($1.2m) | ($2.4m) | ($2.2m) | |
| Change In Account Payable | — | — | — | — | — | $2.6m | $8.0m | $3.1m | ($6.9m) | ($11.8m) | |
| Change In Other Working Capital | — | — | — | — | — | ($2.1m) | $69.0m | ($32.0m) | ($69.2m) | ($57.7m) | |
| Change In Payable | — | — | — | — | — | $2.6m | $8.0m | $3.1m | ($6.9m) | ($11.8m) | |
| Change In Prepaid Assets | — | — | — | — | — | ($2.0m) | ($2.1m) | ($2.0m) | ($5.8m) | $3.4m | |
| Changes In Cash | — | — | — | — | — | ($98.4m) | $186.5m | $353.8m | ($252.2m) | ($208.4m) | |
| End Cash Position | — | — | — | — | — | $339.2m | $527.0m | $880.1m | $628.7m | $513.6m | |
| Financing Cash Flow | — | — | — | — | — | $6.7m |
$250.0m
+3636.21%
|
$519.8m
+107.88%
|
($131k)
-100.03%
|
($149k)
-13.74%
|
|
| Free Cash Flow | — | — | — | — | — | ($105.1m) | ($63.6m) | ($166.0m) | ($252.0m) | ($208.3m) | |
| Investing Cash Flow | — | — | — | — | — | ($19.0m) | ($2.9m) | ($1.2m) | ($2.4m) | ($2.2m) | |
| Net PPE Purchase And Sale | — | — | — | — | — | ($19.0m) | ($2.9m) | ($1.2m) | ($2.4m) | ($2.2m) | |
| Other Non Cash Items | — | — | — | — | $468k | $442k | $1.0m | ($3.2m) | — | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | $989k | $682k | $7.5m | $37k | $47k | |
| Purchase Of PPE | — | — | — | — | — | ($19.0m) | ($2.9m) | ($1.2m) | ($2.4m) | ($2.2m) | |
| Stock Based Compensation | — | — | — | — | — | $26.8m | $32.5m | $38.1m | $39.5m | $33.8m | |
| Cash and cash equivalents | — | — | — | — | $438.7m | $339.2m | $526.4m | $879.5m | $628.1m | $722.0m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | ($99.5m) | $187.8m | $353.1m | ($251.4m) | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | $378k | $2.5m | $2.8m | $2.8m | $1.4m | $78k | — | |
| Income Taxes Paid, Net | — | $73k | $117k | $124k | $73k | $2.2m | $562k | $792k | ($717k) | — |